Giao Quynhthi Phan MD
Endocrine, Melanoma, Surgical Oncology (Other than Breast)
Physician
Join to View Full Profile
UConn Health/Neag Cancer Center263 Farmington AveFarmington, CT 06030
Phone+1 860-679-2100
Fax+1 860-679-4739
Dr. Phan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of South Florida Morsani/Moffitt Cancer CenterFellowship, Complex General Surgical Oncology, 2007 - 2009
Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 2004 - 2007
National Cancer InstituteFellowship, Complex General Surgical Oncology, 1999 - 2004
Ohio State University HospitalResidency, Surgery, 1997 - 1999
Johns Hopkins University School of MedicineClass of 1997
Certifications & Licensure
CT State Medical License 2023 - 2025
VA State Medical License 2014 - 2024
MD State Medical License 2000 - 2017
OH State Medical License 1999 - 2000
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow American College of Surgeons
Clinical Trials
- Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma Start of enrollment: 2019 Dec 17
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- A feasibility double-blind trial of levothyroxine vs. levothyroxine-liothyronine in postsurgical hypothyroidism.Giao Q Phan, Sahzene Yavuz, Angeliki M Stamatouli, Ritu Madan, Shanshan Chen
Frontiers in Endocrinology. 2025-01-01 - 4 citationsAdoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies.John Haanen, Christy Los, Giao Q Phan, Allison Betof Warner
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01 - 278 citationsNeoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright Jr, Kathleen J Yost
The New England Journal of Medicine. 2023-03-02
Press Mentions
Top Docs 2020April 27th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
